U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

CDC Public Access

CDC Stacks Public Health Publications

Items in this collection are manuscripts and articles written by CDC or CDC-funded authors, and published in scholarly journals outside CDC. These items are available in compliance with the 2024 update of CDC-GA-2013-01 CDC Public Access to CDC-Funded Publications, available at: https://stacks.cdc.gov/view/cdc/159734.

(1)
(49)
(1130)
(1297)
(1473)
(1636)
(1721)
(2089)
(2467)
(2387)
(2565)
(2657)
(2463)
(2137)
(1509)
(782)
(243)
(186)
(133)
(120)
(115)
(87)
(45)
(52)
(57)
(52)
(20)
(14)
(19)
(17)
(10)
(15)
(8)
(7)
(4)
(5)
(5)
(7)
(2)
(1)
(2)
(2)
(12)
(7)
(3)
(7)
(2)
(1)
(4)
(3)
(11)
(5)
(1)
(2)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(64)
(56)
(37)
(23)
(12)
(4)
0 of 67
(1)
(27239)
(7)
(487)
0 of 4
(4)
(68)
(6)
(11)
(7)
(1)
(30)
(70)
(22)
(65)
(1)
(6)
(15)
(6)
(1)
(7)
(19)
(7)
(1)
(27)
(22)
(1)
(40)
(1)
(11)
(2)
(11)
(1)
(1)
(1)
(1)
(29)
(1)
(15)
(68)
(1)
(1)
(1)
(4)
(1)
(2)
(12)
(1)
(12)
(26)
(48)
(1)
(2)
(17)
(232)
(16)
(18)
(39)
(1)
(2)
(10)
(1)
(4)
(21)
(4)
(1)
(1)
(20)
(1)
(1)
(1)
(4)
(166)
(13)
(48)
(1)
(6)
(2)
(17)
(3)
(12)
(1)
(1)
(3)
(2)
(2)
(2)
(19)
(10)
(1)
(1)
(28)
(3)
(8)
(6)
(15)
(1)
(4)
(7)
(1)
(4)
(56)
(37)
(2)
(1)
(4)
(9)
(56)
(5)
(3)
(6)
(141)
(11)
(4)
(31)
(1)
(2)
(2)
(3)
(3)
(33)
(12)
(1)
(3)
(52)
(8)
(1)
(4)
(7)
(1)
(5)
(1)
(26)
(67)
(16)
(16)
(36)
(2)
(4)
(7)
(5)
(3)
(13)
(7)
(1)
(9)
(4)
(19)
(419)
(1)
(1)
(1)
(1)
(4)
(14)
(1)
(1)
(2)
(3)
(12)
(2)
(1)
(24)
(15)
(12)
(6)
(1)
(66)
(3)
(15)
(1)
(56)
(80)
(3)
(2)
(48)
(1)
(74)
(9)
(3)
(2)
(20)
(45)
(17)
(19)
(3)
(9)
(3)
(57)
(6)
(1)
(19)
(20)
(20)
(3)
(1)
(11)
(1)
(5)
(31)
(8)
(1)
(6)
(1)
(135)
(1)
(1)
(3)
(101)
(1)
(10)
(4)
(5)
(56)
(35)
(1)
(119)
(1)
(1)
(10)
(9)
(120)
(21)
(1)
(36)
(61)
(56)
(182)
(79)
(141)
(43)
(39)
(23)
(58)
(46)
(1)
(10)
(16)
(4)
(5)
(1)
(91)
(31)
(17)
(11)
(2)
(3)
(75)
(1)
(3)
(3)
(1)
(1)
(15)
(1)
(9)
(2)
(12)
(19)
(12)
(1)
(1)
(1)
(6)
(1)
(15)
(1)
(1)
(27)
(1)
(1)
(2)
(11)
(179)
(1)
(16)
(35)
(1)
(20)
(1)
(7)
(6)
(7)
(1)
(3)
(4)
(1)
(6)
(7)
(2)
(1)
(1)
(24)
(3)
(89)
(23)
(116)
(97)
(2)
(5)
(4)
(1)
(1)
(101)
(6)
(1)
(11)
(1)
(2877)
(1)
(7)
(1)
(23)
(4)
(5)
(31)
(23)
(2)
(77)
(1)
(2)
(114)
(17)
(2)
(1)
(1)
(47)
(4)
(31)
0 of 324
(27)
(3)
0 of 2
(38)
(40)
(39)
(70)
(90)
(101)
(131)
(59)
(60)
(95)
(58)
(39)
(38)
(47)
(4696)
(201)
(45)
(7017)
(51)
(56)
(40)
(89)
(132)
(44)
(3034)
(1066)
(190)
(641)
(40)
(62)
(97)
(37)
(174)
(34)
(42)
(35)
(188)
(241)
(114)
(125)
(50)
(169)
(216)
(66)
(51)
(41)
(72)
(91)
(102)
(35)
(40)
(227)
(74)
(52)
(45)
(2415)
(37)
(52)
(37)
(45)
(369)
(327)
(55)
(170)
(68)
(43)
(83)
(291)
(38)
(37)
(61)
(78)
(118)
(39)
(54)
(97)
(125)
(190)
(93)
(59)
(36)
(45)
(52)
(7533)
(53)
(113)
(236)
(37)
(36)
(55)
(40)
(134)
(77)
(115)
(45)
(76)
(67)
(69)
(44)
(90)
(47)
(36)
(100)
(132)
(182)
(36)
(35)
(59)
(37)
(73)
(40)
(325)
(83)
(76)
(39)
(74)
(50)
(516)
(95)
(75)
(91)
(38)
(35)
(345)
(96)
(38)
(37)
(156)
(65)
(44)
(78)
(112)
(330)
(59)
(80)
(47)
(43)
(34)
(49)
(73)
(168)
(70)
(40)
(72)
(65)
(204)
(94)
(41)
(57)
(665)
(42)
(37)
(86)
(174)
(133)
(62)
(150)
(69)
(62)
(121)
(54)
(245)
(42)
(41)
(3097)
(2116)
(86)
(35)
(60)
(36)
(44)
(34)
(62)
(51)
(55)
(112)
(43)
(40)
(101)
(76)
(154)
(39)
(37)
(48)
(104)
(38)
(51)
(53)
(35)
(57)
(50)
(47)
(80)
(38)
(54)
(180)
(36)
(49)
(82)
(779)
(105)
(43)
(39)
(165)
(36)
(89)
(130)
(89)
(160)
(45)
(88)
(49)
(35)
(86)
(67)
(222)
(58)
(137)
(120)
(84)
(105)
(67)
(82)
(62)
(106)
(51)
(126)
(84)
(253)
(146)
(77)
(136)
(431)
(81)
(41)
(125)
(1560)
(206)
(35)
(51)
(53)
(45)
(103)
(52)
(250)
(262)
(54)
(108)
(36)
(36)
(263)
(124)
(90)
(43)
(196)
(36)
(122)
(66)
(37)
(218)
(118)
(194)
(34)
(63)
(128)
(200)
(78)
(37)
(34)
(91)
(92)
(69)
(111)
(48)
(221)
(41)
(670)
(91)
(35)
(36)
(88)
(37)
(55)
(93)
(68)
(44)
(35)
(44)
(113)
(90)
(37)
(41)
(64)
(58)
(46)
(138)
(72)
(39)
(114)
(70)
(75)
(69)
(46)
(45)
(215)
(265)
(49)
(50)
(37)
(138)
(134)
(78)
(37)
(37)
(62)
(43)
(259)
(125)
(41)
(136)
(51)
(51)
(78)
(523)
(83)
(412)
(183)
(58)
(107)
(106)
(206)
(57)
(49)
(140)
(102)
(67)
(60)
(99)
(54)
(38)
(68)
(35)
(37)
(349)
(35)
(92)
(62)
(79)
(269)
(94)
(179)
(59)
(77)
(50)
(104)
(179)
(93)
(10418)
(41)
(62)
(51)
(69)
(82)
(42)
(55)
(37)
(60)
(168)
(79)
(423)
(39)
(92)
(62)
(43)
(39)
(68)
(36)
(74)
(36)
(73)
(40)
(134)
(52)
(52)
(73)
(91)
(168)
(58)
(175)
(49)
(79)
(86)
(106)
(368)
(66)
(130)
(62)
(73)
(256)
(37)
(176)
(126)
(69)
(39)
(46)
(295)
(153)
(173)
(174)
(134)
(50)
(96)
(110)
(564)
(360)
(55)
(211)
(427)
(59)
(52)
(318)
(87)
(74)
(205)
(207)
(43)
(404)
(52)
(103)
(41)
(35)
(39)
(37)
(45)
(42)
(50)
(99)
(88)
(100)
(39)
(36)
(58)
(52)
(137)
(53)
(53)
(70)
(455)
(67)
(90)
(288)
(190)
(1673)
(79)
(39)
(57)
(367)
(495)
(53)
(187)
(55)
(82)
(118)
(18096)
(175)
(34)
(47)
(117)
(239)
(96)
(66)
(106)
(50)
(34)
(959)
(120)
(86)
(81)
(2010)
(44)
(1278)
(45)
(51)
(115)
(172)
(125)
(69)
(57)
(728)
(115)
(218)
(84)
(53)
(38)
(52)
(380)
(59)
(221)
(42)
(57)
(138)
(80)
(37)
(163)
(85)
(40)
(49)
(38)
(58)
(83)
(43)
(130)
(102)
(263)
(101)
(49)
(45)
(60)
(63)
(90)
(39)
(46)
(86)
(36)
(43)
(56)
(40)
(70)
(70)
(70)
(95)
(34)
(95)
(183)
(34)
(49)
(46)
(39)
(39)
(43)
(607)
(36)
(462)
(235)
(56)
(124)
(49)
(61)
(49)
(46)
(68)
(273)
(101)
(8895)
(37)
(34)
(45)
(66)
(547)
(75)
(72)
(155)
(35)
(84)
(45)
(153)
(53)
(46)
(164)
(142)
(57)
(39)
(38)
(40)
(118)
(169)
(62)
(35)
(57)
(38)
(49)
(43)
(583)
(91)
(161)
(45)
(74)
(158)
(35)
(45)
(5065)
(50)
(101)
(85)
(40)
(136)
(73)
(197)
(194)
(53)
(67)
(194)
(37)
(62)
(116)
(102)
(50)
(185)
(70)
(87)
(47)
(49)
(54)
(266)
(45)
(50)
(173)
(105)
(35)
(87)
(77)
(48)
(47)
(44)
(79)
(83)
(36)
(70)
(419)
(100)
(46)
(41)
(69)
(50)
(73)
(87)
(41)
(35)
(45)
(42)
(138)
(46)
(81)
(65)
(41)
(63)
(56)
(70)
(49)
(419)
(37)
(338)
(52)
(396)
(942)
(647)
(156)
(111)
(367)
(51)
(36)
(164)
(37)
(34)
(43)
(74)
(38)
(70)
(83)
(82)
(37)
(88)
(77)
(39)
(100)
(35)
(58)
(41)
(322)
(54)
(165)
(134)
(64)
(48)
(212)
(149)
(202)
(294)
(93)
(44)
(106)
(37)
(44)
(44)
(73)
(64)
(79)
(64)
(56)
(114)
(37)
(53)
(127)
(55)
(322)
(36)
(50)
(75)
(221)
(96)
(72)
(87)
(108)
(48)
(38)
(42)
(82)
(65)
(155)
(92)
(51)
(79)
(52)
(42)
(179)
(47)
(179)
(779)
(68)
(240)
(38)
(202)
(193)
(123)
(42)
(129)
(1626)
(71)
(38)
(127)
(276)
(134)
(64)
(102)
(126)
(154)
(43)
(1624)
(49)
(89)
(165)
(36)
(39)
(37)
(35)
(185)
(107)
(318)
(57)
(206)
(642)
(91)
(36)
(57)
(38)
(40)
(38)
(55)
(650)
(71)
(79)
(74)
(158)
(37)
(41)
(70)
(36)
(235)
(63)
(38)
(65)
(98)
(72)
(244)
(151)
(40)
(74)
(38)
(200)
(93)
(194)
(109)
(41)
(43)
(140)
(41)
(46)
(53)
(68)
(105)
(55)
(486)
(207)
(376)
(60)
(44)
(619)
(454)
(150)
(332)
(39)
(87)
(55)
(85)
(95)
(145)
(47)
(1012)
(103)
(117)
(213)
(329)
(580)
(2072)
(36)
(36)
(73)
(62)
(37)
(209)
(43)
(36)
(116)
(155)
(124)
(44)
(40)
(354)
(36)
(297)
(70)
(45)
(39)
(40)
(220)
(80)
(315)
(288)
(90)
(37)
(45)
(49)
(308)
(333)
(128)
(43)
(101)
(39)
(183)
(139)
(63)
(65)
(56)
(201)
(152)
(391)
(85)
(235)
(469)
(276)
(254)
(108)
(63)
(79)
(54)
(103)
(59)
(346)
(105)
(35)
(48)
(107)
(59)
(56)
(39)
(60)
(161)
(602)
(77)
(35)
(42)
(77)
(69)
(59)
(48)
(43)
(57)
(61)
(42)
(53)
(75)
(36)
(157)
(87)
(73)
(241)
(227)
(109)
(59)
(110)
(37)
(37)
(110)
(50)
(1182)
(132)
(105)
(110)
(90)
(122)
(43)
(140)
(69)
(38)
(71)
(37)
(53)
(41)
(42)
(691)
(94)
(82)
(36)
(54)
(80)
(46)
(65)
(138)
(415)
(255)
(56)
(65)
(36)
(39)
(2828)
(51)
(78)
(244)
(39)
(169)
(787)
(75)
(139)
(92)
(52)
(47)
(44)
(41)
(72)
(42)
(53)
(47)
(239)
(230)
(64)
(41)
(58)
(45)
(53)
(88)
(45)
(49)
(74)
(93)
(85)
(43)
(38)
(59)
(62)
(46)
(50)
(45)
(48)
(50)
(65)
(301)
(44)
(72)
(66)
(62)
(39)
(288)
(69)
(65)
(37)
(137)
(4060)
(83)
(99)
(122)
0 of 1000
(17)
(17)
(17)
(29)
(24)
(22)
(17)
(26)
(20)
(18)
(20)
(20)
(17)
(18)
(33)
(81)
(28)
(23)
(32)
(22)
(19)
(26)
(17)
(17)
(19)
(29)
(21)
(22)
(59)
(41)
(28)
(27)
(31)
(47)
(19)
(36)
(21)
(57)
(23)
(19)
(56)
(32)
(43)
(24)
(41)
(21)
(31)
(26)
(59)
(44)
(17)
(47)
(33)
(22)
(29)
(23)
(20)
(17)
(33)
(17)
(23)
(40)
(29)
(20)
(24)
(19)
(30)
(26)
(25)
(26)
(19)
(37)
(22)
(17)
(26)
(22)
(42)
(66)
(26)
(20)
(17)
(25)
(27)
(27)
(63)
(45)
(20)
(25)
(34)
(31)
(24)
(20)
(24)
(72)
(17)
(22)
(30)
(47)
(24)
(24)
(18)
(48)
(50)
(21)
(30)
(22)
(25)
(39)
(29)
(27)
(20)
(48)
(24)
(31)
(25)
(17)
(31)
(176)
(26)
(40)
(23)
(51)
(21)
(35)
(44)
(29)
(20)
(46)
(23)
(57)
(20)
(19)
(46)
(18)
(27)
(18)
(20)
(22)
(20)
(24)
(20)
(31)
(29)
(40)
(19)
(44)
(19)
(18)
(25)
(18)
(32)
(49)
(66)
(22)
(24)
(26)
(40)
(18)
(18)
(35)
(24)
(18)
(18)
(23)
(31)
(21)
(29)
(23)
(22)
(50)
(24)
(32)
(64)
(18)
(60)
(19)
(94)
(48)
(34)
(34)
(19)
(22)
(20)
(41)
(28)
(37)
(28)
(20)
(20)
(29)
(30)
(30)
(20)
(23)
(18)
(22)
(24)
(29)
(25)
(24)
(18)
(39)
(27)
(27)
(24)
(35)
(28)
(23)
(34)
(21)
(29)
(18)
(18)
(24)
(22)
(23)
(18)
(22)
(23)
(19)
(29)
(36)
(29)
(20)
(19)
(22)
(23)
(19)
(30)
(27)
(29)
(48)
(63)
(72)
(28)
(23)
(30)
(49)
(22)
(18)
(31)
(21)
(24)
(28)
(21)
(31)
(24)
(33)
(33)
(51)
(19)
(20)
(57)
(57)
(42)
(23)
(23)
(30)
(28)
(38)
(18)
(35)
(47)
(20)
(34)
(30)
(19)
(54)
(29)
(29)
(38)
(60)
(41)
(19)
(29)
(19)
(21)
(19)
(33)
(19)
(24)
(19)
(26)
(21)
(43)
(82)
(37)
(23)
(23)
(29)
(42)
(24)
(20)
(26)
(19)
(27)
(21)
(27)
(23)
(38)
(29)
(54)
(23)
(18)
(20)
(115)
(24)
(30)
(20)
(27)
(29)
(104)
(20)
(29)
(24)
(19)
(19)
(49)
(32)
(37)
(21)
(22)
(27)
(25)
(53)
(22)
(20)
(20)
(32)
(19)
(20)
(24)
(21)
(24)
(19)
(23)
(42)
(39)
(31)
(23)
(45)
(32)
(30)
(25)
(19)
(21)
(27)
(33)
(23)
(36)
(22)
(19)
(18)
(18)
(22)
(19)
(43)
(19)
(25)
(18)
(18)
(28)
(22)
(23)
(26)
(24)
(21)
(45)
(35)
(67)
(24)
(26)
(18)
(20)
(24)
(18)
(18)
(19)
(18)
(23)
(18)
(25)
(18)
(32)
(32)
(21)
(22)
(86)
(25)
(23)
(20)
(29)
(41)
(37)
(27)
(18)
(30)
(30)
(132)
(19)
(22)
(21)
(27)
(20)
(50)
(18)
(46)
(37)
(36)
(33)
(26)
(20)
(22)
(50)
(27)
(24)
(21)
(19)
(37)
(21)
(19)
(21)
(51)
(22)
(59)
(21)
(35)
(19)
(18)
(20)
(25)
(38)
(18)
(26)
(23)
(26)
(66)
(24)
(41)
(18)
(21)
(28)
(60)
(21)
(56)
(48)
(22)
(67)
(21)
(64)
(24)
(30)
(31)
(47)
(27)
(22)
(23)
(32)
(59)
(19)
(18)
(22)
(39)
(22)
(20)
(36)
(21)
(38)
(21)
(18)
(29)
(38)
(22)
(27)
(32)
(19)
(30)
(20)
(61)
(27)
(31)
(19)
(26)
(20)
(18)
(28)
(33)
(24)
(18)
(29)
(21)
(26)
(21)
(28)
(18)
(27)
(32)
(21)
(27)
(25)
(18)
(30)
(24)
(22)
(31)
(28)
(19)
(23)
(25)
(27)
(49)
(27)
(24)
(28)
(54)
(38)
(29)
(28)
(26)
(35)
(20)
(18)
(46)
(21)
(26)
(34)
(19)
(42)
(20)
(25)
(21)
(23)
(40)
(43)
(61)
(19)
(20)
(24)
(24)
(61)
(27)
(24)
(27)
(25)
(18)
(21)
(26)
(23)
(65)
(21)
(28)
(21)
(18)
(19)
(34)
(18)
(23)
(52)
(37)
(21)
(18)
(40)
(18)
(36)
(19)
(29)
(33)
(19)
(22)
(20)
(36)
(18)
(31)
(34)
(19)
(34)
(33)
(22)
(20)
(27)
(24)
(23)
(19)
(26)
(32)
(21)
(34)
(21)
(21)
(34)
(18)
(18)
(20)
(25)
(19)
(19)
(40)
(30)
(26)
(24)
(39)
(41)
(29)
(21)
(19)
(31)
(20)
(19)
(45)
(22)
(20)
(25)
(51)
(32)
(28)
(24)
(28)
(18)
(19)
(61)
(22)
(74)
(21)
(21)
(22)
(28)
(32)
(18)
(46)
(37)
(21)
(30)
(23)
(39)
(32)
(20)
(34)
(20)
(20)
(27)
(23)
(43)
(19)
(19)
(25)
(23)
(34)
(28)
(31)
(29)
(30)
(24)
(50)
(21)
(22)
(44)
(113)
(23)
(18)
(21)
(54)
(36)
(20)
(18)
(32)
(19)
(19)
(26)
(18)
(30)
(20)
(18)
(40)
(64)
(30)
(33)
(32)
(22)
(43)
(32)
(35)
(42)
(24)
(18)
(44)
(24)
(49)
(23)
(26)
(25)
(48)
(27)
(24)
(22)
(19)
(34)
(19)
(18)
(20)
(23)
(27)
(22)
(30)
(45)
(28)
(43)
(66)
(28)
(24)
(19)
(22)
(27)
(30)
(18)
(19)
(25)
(23)
(63)
(29)
(30)
(31)
(23)
(20)
(23)
(28)
(21)
(25)
(19)
(30)
(20)
(19)
(29)
(30)
(109)
(36)
(28)
(42)
(24)
(25)
(21)
(18)
(18)
(24)
(23)
(20)
(23)
(41)
(19)
(29)
(19)
(40)
(22)
(25)
(18)
(96)
(19)
(56)
(38)
(21)
(18)
(48)
(58)
(24)
(28)
(19)
(18)
(27)
(34)
(38)
(22)
(25)
(19)
(28)
(26)
(18)
(18)
(19)
(34)
(27)
(19)
(30)
(22)
(79)
(22)
(24)
(18)
(18)
(28)
(29)
(18)
(22)
(33)
(19)
(23)
(21)
(25)
(25)
(47)
(41)
(25)
(58)
(21)
(24)
(44)
(38)
(52)
(44)
(30)
(24)
(28)
(58)
(23)
(30)
(37)
(27)
(23)
(46)
(18)
(47)
(34)
(25)
(22)
(31)
(18)
(24)
(20)
(23)
(21)
(22)
(27)
(29)
(18)
(88)
(18)
(72)
(41)
(25)
(18)
(21)
(18)
(19)
(30)
(21)
(21)
(49)
(30)
(32)
(29)
(46)
(18)
(24)
(58)
(35)
(30)
(28)
(32)
(23)
(21)
(61)
(20)
(22)
(20)
(20)
(37)
(22)
(51)
(19)
(18)
(70)
(59)
(20)
(18)
(18)
(24)
(27)
(29)
(26)
(18)
(23)
(21)
(18)
(29)
(22)
(29)
(54)
(68)
(29)
(23)
(31)
(26)
(40)
(21)
(18)
(18)
(44)
(22)
(22)
(49)
(36)
(30)
(18)
(22)
(39)
(26)
(19)
(54)
(34)
(39)
(38)
(29)
(21)
(38)
(21)
(43)
(23)
(22)
(20)
(26)
(32)
(33)
(26)
(19)
(22)
(20)
(24)
(22)
(21)
(37)
(32)
(20)
(19)
(21)
(41)
(41)
(34)
(56)
(22)
(27)
(26)
(20)
(30)
(29)
(22)
(34)
(34)
(27)
(26)
(22)
(20)
(22)
(19)
(29)
(35)
(26)
(34)
(18)
(25)
(24)
(35)
(39)
(24)
(23)
(24)
(22)
(39)
(26)
(21)
(23)
(18)
(54)
(39)
(25)
(20)
(19)
(22)
(20)
(21)
(19)
(18)
(18)
(20)
(19)
(36)
(55)
(27)
(19)
(36)
(29)
(44)
(21)
(26)
(24)
(29)
(21)
(19)
(19)
(22)
(39)
(62)
(35)
0 of 1000
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(29)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(16)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(7)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(205)
(1)
(25)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(4)
(6)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(2)
(5)
(5)
(2)
(6)
(1)
(1)
(3)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(4)
(7)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(6)
(88)
(1)
(1)
(1)
(1)
(1)
(20)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(2)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(29)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
0 of 751
(1)
(24)
(1)
(1)
(35)
(1)
(1)
(49)
(2)
(1)
(18)
(1)
(474)
(19)
(2)
(1)
(2)
(1)
(1)
(4)
(8)
(1)
(24)
(1)
(3)
(2)
(1)
(4)
0 of 28
(10)
(20)
(13)
(9)
(11)
(8)
(8)
(11)
(17)
(20)
(11)
(458)
(28)
(22)
(9)
(61)
(42)
(618)
(17)
(9)
(19)
(10)
(8)
(12)
(17)
(41)
(30)
(13)
(281)
(98)
(22)
(70)
(12)
(23)
(15)
(27)
(12)
(18)
(16)
(15)
(23)
(13)
(12)
(15)
(8)
(8)
(9)
(26)
(17)
(17)
(17)
(9)
(9)
(74)
(74)
(18)
(9)
(15)
(15)
(12)
(9)
(31)
(15)
(8)
(148)
(40)
(38)
(27)
(11)
(11)
(15)
(16)
(31)
(10)
(15)
(21)
(75)
(13)
(14)
(12)
(13)
(12)
(10)
(21)
(9)
(9)
(41)
(38)
(9)
(17)
(14)
(11)
(19)
(12)
(12)
(13)
(9)
(17)
(29)
(9)
(19)
(8)
(54)
(18)
(9)
(18)
(10)
(52)
(10)
(10)
(52)
(8)
(27)
(21)
(16)
(51)
(14)
(16)
(14)
(14)
(8)
(10)
(10)
(9)
(11)
(32)
(31)
(30)
(23)
(29)
(18)
(16)
(17)
(16)
(152)
(9)
(36)
(53)
(18)
(9)
(8)
(11)
(14)
(8)
(10)
(9)
(23)
(41)
(10)
(13)
(48)
(20)
(18)
(17)
(66)
(13)
(8)
(298)
(13)
(165)
(14)
(8)
(12)
(17)
(93)
(38)
(18)
(13)
(9)
(11)
(150)
(24)
(21)
(8)
(10)
(9)
(12)
(9)
(12)
(12)
(8)
(10)
(9)
(64)
(8)
(10)
(9)
(18)
(11)
(13)
(11)
(10)
(14)
(14)
(10)
(12)
(12)
(9)
(27)
(11)
(8)
(20)
(11)
(10)
(13)
(11)
(10)
(20)
(15)
(8)
(21)
(31)
(14)
(21)
(11)
(14)
(11)
(10)
(169)
(12)
(9)
(19)
(153)
(35)
(9)
(15)
(15)
(11)
(12)
(31)
(19)
(9)
(51)
(40)
(9)
(13)
(8)
(41)
(18)
(21)
(20)
(21)
(10)
(18)
(14)
(34)
(27)
(18)
(15)
(13)
(13)
(8)
(10)
(9)
(9)
(38)
(14)
(9)
(8)
(42)
(22)
(9)
(21)
(8)
(11)
(13)
(11)
(8)
(24)
(16)
(27)
(8)
(8)
(10)
(8)
(21)
(14)
(15)
(9)
(17)
(10)
(10)
(18)
(8)
(9)
(30)
(19)
(12)
(14)
(10)
(44)
(10)
(12)
(10)
(33)
(28)
(13)
(15)
(199)
(83)
(18)
(11)
(13)
(10)
(21)
(8)
(10)
(47)
(14)
(30)
(20)
(13)
(28)
(34)
(26)
(25)
(13)
(19)
(11)
(8)
(11)
(11)
(9)
(11)
(20)
(9)
(14)
(13)
(1004)
(9)
(11)
(15)
(11)
(9)
(18)
(10)
(21)
(17)
(36)
(8)
(9)
(9)
(10)
(12)
(9)
(10)
(9)
(11)
(13)
(10)
(28)
(24)
(18)
(10)
(26)
(8)
(8)
(32)
(16)
(11)
(13)
(14)
(11)
(12)
(9)
(15)
(8)
(42)
(13)
(14)
(10)
(18)
(17)
(13)
(11)
(43)
(21)
(17)
(25)
(14)
(10)
(9)
(11)
(9)
(8)
(47)
(40)
(9)
(29)
(14)
(57)
(26)
(8)
(35)
(13)
(13)
(23)
(25)
(9)
(54)
(9)
(10)
(10)
(10)
(9)
(10)
(14)
(12)
(8)
(25)
(24)
(8)
(8)
(75)
(9)
(16)
(8)
(46)
(11)
(345)
(27)
(46)
(10)
(8)
(194)
(48)
(12)
(28)
(9)
(39)
(49)
(25)
(26)
(8)
(150)
(15)
(13)
(9)
(9)
(12)
(88)
(8)
(1885)
(50)
(42)
(11)
(39)
(25)
(23)
(8)
(13)
(11)
(14)
(13)
(107)
(37)
(10)
(15)
(12)
(184)
(12)
(133)
(9)
(9)
(8)
(18)
(15)
(25)
(34)
(23)
(49)
(33)
(41)
(9)
(10)
(11)
(8)
(23)
(9)
(21)
(9)
(25)
(18)
(14)
(11)
(9)
(14)
(9)
(10)
(14)
(10)
(10)
(28)
(12)
(17)
(17)
(14)
(11)
(10)
(22)
(28)
(37)
(10)
(9)
(8)
(15)
(14)
(9)
(8)
(11)
(17)
(11)
(8)
(55)
(9)
(50)
(18)
(9)
(11)
(10)
(9)
(29)
(12)
(13)
(14)
(12)
(9)
(17)
(811)
(9)
(8)
(9)
(8)
(13)
(13)
(44)
(12)
(11)
(10)
(23)
(19)
(10)
(64)
(31)
(16)
(8)
(18)
(57)
(25)
(22)
(35)
(14)
(13)
(9)
(12)
(17)
(13)
(141)
(10)
(37)
(14)
(17)
(428)
(9)
(11)
(13)
(9)
(9)
(12)
(12)
(13)
(172)
(77)
(22)
(11)
(10)
(14)
(27)
(19)
(9)
(9)
(11)
(22)
(9)
(136)
(8)
(8)
(8)
(8)
(10)
(14)
(64)
(13)
(11)
(9)
(11)
(26)
(64)
(9)
(11)
(15)
(14)
(11)
(20)
(11)
(11)
(40)
(13)
(13)
(52)
(82)
(57)
(21)
(18)
(8)
(41)
(91)
(28)
(8)
(44)
(40)
(8)
(11)
(9)
(13)
(15)
(40)
(16)
(9)
(9)
(15)
(13)
(23)
(19)
(17)
(17)
(9)
(9)
(28)
(9)
(11)
(12)
(10)
(18)
(9)
(20)
(10)
(10)
(20)
(19)
(16)
(11)
(16)
(19)
(11)
(17)
(26)
(16)
(28)
(11)
(11)
(31)
(10)
(20)
(14)
(10)
(9)
(13)
(10)
(17)
(11)
(11)
(14)
(68)
(21)
(11)
(9)
(18)
(15)
(9)
(16)
(11)
(8)
(31)
(27)
(24)
(8)
(22)
(20)
(8)
(8)
(9)
(9)
(10)
(70)
(13)
(8)
(9)
(13)
(34)
(22)
(30)
(17)
(15)
(13)
(17)
(245)
(107)
(21)
(26)
(11)
(15)
(11)
(16)
(10)
(20)
(27)
(9)
(16)
(12)
(186)
(57)
(72)
(36)
(8)
(13)
(19)
(26)
(13)
(19)
(18)
(26)
(14)
(8)
(14)
(52)
(16)
(9)
(15)
(96)
(96)
(23)
(15)
(12)
(9)
(17)
(17)
(17)
(24)
(23)
(10)
(21)
(11)
(8)
(23)
(16)
(19)
(16)
(32)
(9)
(8)
(10)
(16)
(9)
(9)
(37)
(11)
(13)
(9)
(38)
(11)
(8)
(8)
(14)
(12)
(23)
(10)
(16)
(11)
(11)
(9)
(105)
(11)
(25)
(9)
(27)
(58)
(14)
(234)
(60)
(23)
(10)
(23)
(19)
(10)
(12)
(9)
(9)
(22)
(11)
(18)
(8)
(26)
(23)
(8)
(150)
(14)
(48)
(9)
(9)
(36)
(11)
(31)
(24)
(20)
(14)
(25)
(16)
(13)
(8)
(9)
(9)
(8)
(9)
(9)
(26)
(46)
(10)
(30)
(54)
(9)
(28)
(24)
(8)
(27)
(15)
(13)
(9)
(9)
(15)
(15)
(8)
(8)
(54)
(19)
(15)
(32)
(19)
(17)
(9)
(14)
(10)
(16)
(11)
(67)
(10)
(37)
(8)
(14)
(8)
(12)
(9)
(9)
(8)
(9)
(10)
(11)
(21)
(18)
(8)
(18)
(18)
(22)
(22)
(11)
(32)
(11)
(26)
(22)
(30)
(19)
(8)
(141)
(66)
(24)
(16)
(136)
(26)
(8)
(10)
(15)
(23)
(10)
(8)
(20)
(15)
(18)
(17)
(9)
(15)
(15)
(16)
(10)
(14)
(9)
(11)
(12)
(13)
(17)
(55)
(17)
(17)
(9)
(9)
(75)
(9)
(12)
(11)
(11)
(11)
(9)
(18)
(12)
(10)
(20)
(14)
(19)
(143)
(37)
(40)
(32)
(12)
(60)
(52)
(16)
(9)
(13)
(10)
(20)
(683)
(9)
(14)
(11)
(15)
(123)
(36)
(12)
(12)
(33)
(24)
(13)
(36)
(20)
(26)
(23)
(10)
(14)
(11)
(54)
(23)
(10)
(9)
(20)
(18)
(11)
(9)
(10)
(9)
(10)
(10)
(12)
(10)
(9)
(11)
(27)
(77)
(78)
(24)
(12)
(10)
(9)
(10)
(9)
(16)
(48)
(13)
(14)
(13)
(12)
(9)
(359)
(9)
(45)
(27)
(9)
(9)
(17)
(10)
(12)
(11)
0 of 1000
Showing 201 - 220 of 27871 results
  • SARSCoV2 correlates of protection from infection against variants of concern
    SARS-CoV-2 correlates of protection from infection against variants of concern
    Sun, Kaiyuan ;
    Bhiman, Jinal N.
    10 2024 | Nat Med. 30(10):2805-2812
    Serum neutralizing antibodies (nAbs) induced by vaccination have been linked to protection against symptomatic and severe coronavirus disease 2019. However, much less is known about the efficacy of nAbs in preventing the acquisition of infection, especially in the context of natural immunity and against severe acute respiratory syndrome coronavirus ...
    Supporting Files
  • Strengthening Maternal and Infant Health Resilience Before Weather and Climate Disasters Preparedness Resources from CDCs Division of Reproductive Health
    Strengthening Maternal and Infant Health Resilience Before Weather and Climate Disasters: Preparedness Resources from CDC’s Division of Reproductive Health
    Galang, Romeo R. ;
    Meeker, Jessica R.
    2024/10/01 | J Womens Health (Larchmt). 33(10):1289-1295 | National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
    This report describes opportunities to address emergency preparedness to incorporate the needs of pregnant and postpartum populations. This report briefly summarizes data on the impacts of weather and climate disasters on maternal and infant health and outlines opportunities for individuals, health care providers, and public health practitioners to ...
    Supporting Files
  • Physical Intimate Partner Violence and Increased Partner Aggression During Pregnancy During the COVID19 Pandemic Results From the Pregnancy Risk Assessment Monitoring System
    Physical Intimate Partner Violence and Increased Partner Aggression During Pregnancy During the COVID-19 Pandemic: Results From the Pregnancy Risk Assessment Monitoring System
    D’Angelo, Denise V. ;
    Kapaya, Martha
    9 28 2024 | Public Health Rep. 140(1 Suppl):20S-31S
    Objectives:Public health emergencies can elevate the risk for intimate partner violence (IPV). Our objectives were 2-fold: first, to assess the prevalence of physical IPV and increased aggression from a husband or partner that occurred during pregnancy and was perceived to be due to the COVID-19 pandemic; second, to examine associations between the ...
    Supporting Files
  • Antimicrobial resistance at a crossroads the cost of inaction
    Antimicrobial resistance at a crossroads: the cost of inaction
    Craig, Michael ;
    Jernigan, Daniel
    9 21 2024 | Lancet. 404(10458):1083-1085
    No Description
    Supporting Files
  • Trends in Contacts Made by Immigrants to the National Domestic Violence Hotline Before and During the COVID19 Pandemic
    Trends in Contacts Made by Immigrants to the National Domestic Violence Hotline, Before and During the COVID-19 Pandemic
    Treves-Kagan, Sarah ;
    Le, Vi D.
    9 20 2024 | Public Health Rep. 140(1 Suppl):90S-99S
    Objectives:Immigrants in the United States are more likely than nonimmigrants to experience risk factors for intimate partner violence (IPV) and problems in getting support. The COVID-19 pandemic and recent incidents of xenophobia and anti-immigrant sentiment may have exacerbated exposure to IPV risk factors. We examined immigrant experiences of IP ...
    Supporting Files
  • Using machine learning to discover traumatic brain injury patient phenotypes national concussion surveillance system Pilot
    Using machine learning to discover traumatic brain injury patient phenotypes: national concussion surveillance system Pilot
    Waltzman, Dana ;
    Daugherty, Jill
    9 18 2024 | Brain Inj. 38(11):880-888
    Objective:The objective is to determine whether unsupervised machine learning identifies traumatic brain injury (TBI) phenotypes with unique clinical profiles.Methods:Pilot self-reported survey data of over 10,000 adults were collected from the Centers for Disease Control and Prevention (CDC)’s National Concussion Surveillance System (NCSS). Respon ...
    Supporting Files
  • Integrating Behavioral Health Into Monitoring and Surveillance During Public Health Emergencies Challenges and Opportunities
    Integrating Behavioral Health Into Monitoring and Surveillance During Public Health Emergencies: Challenges and Opportunities
    Faherty, Laura J. ;
    Vagi, Sara J.
    9 18 2024 | Disaster Med Public Health Prep. 18:e132
    Objective:Limited guidance exists for public health agencies to use existing data sources to conduct monitoring and surveillance of behavioral health (BH) in the context of public health emergencies (PHEs).Methods:We conducted a literature review and environmental scan to identify existing data sources, indicators, and analytic methods that could b ...
    Supporting Files
  • US COVID19 vaccine distribution strategies systems performance and lessons learned December 2020 May 2023
    U.S. COVID-19 vaccine distribution strategies, systems, performance, and lessons learned, December 2020 – May 2023
    Duggar, Christopher ;
    Santoli, Jeanne M.
    9 17 2024 | Vaccine. 42(Suppl 3):125703
    During December 2020 through May 2023, the Centers for Disease Control and Prevention's (CDC) Immunization Services Division supported and executed the largest vaccine distribution effort in U.S. history, delivering nearly one billion doses of COVID-19 vaccine to vaccine providers in all 50 states, District of Columbia, Puerto Rico, Virgin Islands, ...
    Supporting Files
  • Global VAX A US contribution to global COVID19 vaccination efforts 20212023
    Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021–2023
    Dahl, Benjamin A. ;
    Tritter, Beth
    9 17 2024 | Vaccine. 42(Suppl 3):125827
    In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and m ...
    Supporting Files
  • A health equity science approach to assessing drivers of COVID19 vaccination coverage disparities over the course of the COVID19 pandemic United States December 2020December 2022
    A health equity science approach to assessing drivers of COVID-19 vaccination coverage disparities over the course of the COVID-19 pandemic, United States, December 2020–December 2022
    Woolfork, Makhabele Nolana ;
    Haire, Kambria
    9 17 2024 | Vaccine. 42(Suppl 3):126158
    Introduction:Health equity science examines underlying social determinants, or drivers, of health inequities by building an evidence base to guide action across programs, public health surveillance, policy, and communications efforts. A Social Vulnerability Index (SVI) was utilized during the COVID-19 response to identify areas where inequities exi ...
    Supporting Files
  • COVID19 Vaccine Safety Technical VaST Work Group Enhancing vaccine safety monitoring during the pandemic
    COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic
    Markowitz, Lauri E. ;
    Hopkins, Robert H.
    9 17 2024 | Vaccine. 42(Suppl 3):125549
    During the COVID-19 pandemic, candidate COVID-19 vaccines were being developed for potential use in the United States on an unprecedented, accelerated schedule. It was anticipated that once available, under U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) or FDA approval, COVID-19 vaccines would be broadly used and potentia ...
    Supporting Files
  • Building the US COVID19 vaccine effectiveness program Past successes and future directions
    Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions
    Link-Gelles, Ruth ;
    Britton, Amadea
    9-17- | Vaccine. 42(Suppl 3):125492
    COVID-19 vaccines were originally authorized in the United States in December 2020 on the basis of safety, immunogenicity, and clinical efficacy data from randomized controlled trials (RCTs). However, real-world vaccine effectiveness (VE) data are necessary to provide information on how the vaccines work in populations not included in the RCTs (e.g ...
    Supporting Files
  • Lessons learned COVID19 vaccinations and people with disabilities
    Lessons learned: COVID-19 vaccinations and people with disabilities
    Rattay, Karyl ;
    Thierry, JoAnn M.
    9 17 2024 | Vaccine. 42(Suppl 3):125602
    This manuscript is being submitted as a Commentary; Abstract not applicable.
    Supporting Files
  • A Programmatic Update On COVID19 Vaccination in Rural Communities in the United States
    A Programmatic Update On COVID-19 Vaccination in Rural Communities in the United States
    Piasecki, Alexandra M. ;
    Hall, Diane M.
    9 17 2024 | Vaccine. 42(Suppl 3):125897
    When public health experts think of rural barriers to vaccines, they often initially focus on access, which makes sense with a new vaccine during a pandemic. This commentary highlights that there can be more complexity to vaccine uptake in rural communities. What follows are some examples of CDC's efforts to better understand rural health and learn ...
    Supporting Files
  • Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh An openlabel randomized controlled trial
    Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial
    Snider, Cynthia J. ;
    Zaman, Khalequ
    9 17 2024 | Vaccine. 42(22):126216
    In 2012, the Strategic Advisory Group of Experts on Immunization (SAGE) recommended introduction of at least one inactivated poliovirus vaccine (IPV) dose in essential immunization programs. We evaluated systemic humoral and intestinal mucosal immunity of a sequential IPV-bivalent oral poliovirus vaccine (bOPV) schedule compared with a co-administr ...
    Supporting Files
  • Planning for the future of maternal immunization Building on lessons learned from the COVID19 pandemic
    Planning for the future of maternal immunization: Building on lessons learned from the COVID-19 pandemic
    Meaney-Delman, Dana ;
    Carroll, Sarah
    9 17 2024 | Vaccine. 42(Suppl 3):125644
    As the worldwide COVID-19 pandemic unfolded, the clinical and public health community raced to understand SARS-CoV-2 infection and develop life-saving vaccines. Pregnant persons were disproportionately impacted, experiencing more severe illness and adverse pregnancy outcomes. And yet, when COVID-19 vaccines became available in late 2020, safety and ...
    Supporting Files
  • The role of funded partnerships in working towards decreasing COVID19 vaccination disparities United States March 2021December 2022
    The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021—December 2022
    Fiebelkorn, Amy Parker ;
    Adelsberg, Sara
    9 17 2024 | Vaccine. 42(Suppl 3):125551
    During the COVID-19 vaccination rollout from March 2021- December 2022, the Centers for Disease Control and Prevention funded 110 primary and 1051 subrecipient partners at the national, state, local, and community-based level to improve COVID-19 vaccination access, confidence, demand, delivery, and equity in the United States. The partners implemen ...
    Supporting Files
  • Monitoring and Reporting the US COVID19 Vaccination Effort
    Monitoring and Reporting the US COVID-19 Vaccination Effort
    Lynn, Gibbs Scharf ;
    Kafayat, Adeniyi
    9 17 2024 | Vaccine. 42(Suppl 3):125495
    Immunizations are an important tool to reduce the burden of vaccine preventable diseases and improve population health.| High-quality immunization data is essential to inform clinical and public health interventions and respond to outbreaks of vaccine-preventable diseases. To track COVID-19 vaccines and vaccinations, CDC established an integrated n ...
    Supporting Files
  • Characteristics of healthcare personnel with SARSCoV2 infection 10 emerging infections program sites in the United States April 2020December 2021
    Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020–December 2021
    Chea, Nora ;
    Eure, Taniece
    | Infect Control Hosp Epidemiol. 45(9):1-9
    Background:Understanding characteristics of healthcare personnel (HCP) with SARS-CoV-2 infection supports the development and prioritization of interventions to protect this important workforce. We report detailed characteristics of HCP who tested positive for SARS-CoV-2 from April 20, 2020 through December 31, 2021.Methods:CDC collaborated with Em ...
    Supporting Files
  • Adverse events following immunization AEFI with fractional onefifth and onehalf doses of yellow fever vaccine compared to full dose in children 923 months old in Uganda 20192020 Preliminary report
    Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary report
    Casey, Rebecca M. ;
    Najjengo, Marjorie Sserunga
    9-17-2024 | Vaccine. 42(22):126197
    Background:In 2016, the World Health Organization recommended that a fractional dose of yellow fever (YF) vaccine could be used in persons 2 years of age or older in response to an emergency that resulted in a global shortage of available YF vaccine. However, this recommendation did not extend to the youngest age group licensed for YF vaccine becau ...
    Supporting Files
201 - 220 / 27871